Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3762705019 | Product containing precisely dihydroergotamine mesilate 500 microgram/1 each conventional release sublingual tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3762706018 | Dihydroergotamine mesilate 500 microgram sublingual tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
3762707010 | Dihydroergotamine mesylate 500 microgram sublingual tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 1 | |
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has BoSS | Dihydroergotamine mesilate | true | Inferred relationship | Some | 1 | |
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has precise active ingredient | Dihydroergotamine mesilate | true | Inferred relationship | Some | 1 | |
Dihydroergotamine mesilate 500 microgram sublingual tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Is a | Dihydroergotamine only product in oromucosal dose form | true | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Is a | Dihydroergotoxine mesylate | false | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has active ingredient | Ergotamine | false | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has active ingredient | Dihydroergotamine mesilate | false | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Is a | Dihydroergotamine mesylate in oropharyngeal dosage form | false | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has manufactured dose form | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has manufactured dose form | Sublingual tablet | true | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Has manufactured dose form | Oropharyngeal dose form | false | Inferred relationship | Some | ||
Dihydroergotamine mesilate 500 microgram sublingual tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets